PubMed:10352273
Annnotations
jnlpba-st-training
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 14-18 | protein | denotes | CD28 |
| T2 | 110-132 | protein | denotes | costimulatory molecule |
| T3 | 133-137 | protein | denotes | CD28 |
| T4 | 195-202 | cell_type | denotes | T cells |
| T5 | 212-230 | cell_type | denotes | plasmacytoma cells |
| T6 | 241-245 | protein | denotes | CD28 |
| T7 | 410-422 | cell_type | denotes | CD8+ T cells |
| T8 | 445-457 | cell_type | denotes | CD4+ T cells |
| T9 | 478-482 | protein | denotes | CD28 |
| T10 | 626-645 | protein | denotes | site alpha and beta |
| T11 | 658-679 | DNA | denotes | CD28 minimal promoter |
| T12 | 757-770 | cell_type | denotes | CD28+ T cells |
| T13 | 784-803 | cell_line | denotes | transformed B cells |
| T14 | 935-944 | protein | denotes | site beta |
| T15 | 954-964 | protein | denotes | site alpha |
| T16 | 1101-1113 | cell_type | denotes | CD8+ T cells |
| T17 | 1210-1214 | protein | denotes | CD28 |
| T18 | 1228-1240 | cell_type | denotes | CD8+ T cells |
| T19 | 1259-1296 | cell_line | denotes | CD4+CD28null and CD8+CD28null T cells |
| T20 | 1312-1343 | protein | denotes | alpha- and beta-bound complexes |
| T21 | 1376-1403 | cell_type | denotes | chronically activated cells |
| T22 | 1415-1430 | cell_type | denotes | senescent cells |
GENIAcorpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 14-18 | protein_molecule | denotes | CD28 |
| T2 | 40-59 | other_name | denotes | regulatory pathways |
| T3 | 110-132 | protein_family_or_group | denotes | costimulatory molecule |
| T4 | 133-137 | protein_molecule | denotes | CD28 |
| T5 | 144-174 | other_name | denotes | restricted tissue distribution |
| T6 | 195-202 | cell_type | denotes | T cells |
| T7 | 212-230 | cell_type | denotes | plasmacytoma cells |
| T8 | 241-245 | protein_molecule | denotes | CD28 |
| T9 | 330-347 | other_name | denotes | T cell activation |
| T10 | 410-422 | cell_type | denotes | CD8+ T cells |
| T11 | 445-457 | cell_type | denotes | CD4+ T cells |
| T12 | 478-482 | protein_molecule | denotes | CD28 |
| T13 | 509-527 | other_name | denotes | chronic infections |
| T14 | 576-610 | other_name | denotes | nuclear protein-binding activities |
| T15 | 658-662 | protein_molecule | denotes | CD28 |
| T16 | 736-752 | tissue | denotes | lymphoid tissues |
| T17 | 757-770 | cell_type | denotes | CD28+ T cells |
| T18 | 784-803 | cell_line | denotes | transformed B cells |
| T19 | 862-884 | other_name | denotes | replicative senescence |
| T20 | 935-944 | protein_domain_or_region | denotes | site beta |
| T21 | 954-964 | protein_domain_or_region | denotes | site alpha |
| T22 | 964-983 | other_name | denotes | -binding activities |
| T23 | 998-1015 | other_name | denotes | T cell activation |
| T24 | 1101-1113 | cell_type | denotes | CD8+ T cells |
| T25 | 1130-1151 | other_name | denotes | beta-binding profiles |
| T26 | 1210-1214 | protein_molecule | denotes | CD28 |
| T27 | 1228-1240 | cell_type | denotes | CD8+ T cells |
| T28 | 1376-1403 | cell_type | denotes | chronically activated cells |
| T29 | 1415-1430 | cell_type | denotes | senescent cells |
pubmed-sentences-benchmark
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| S1 | 0-105 | Sentence | denotes | Modulation of CD28 expression: distinct regulatory pathways during activation and replicative senescence. |
| S2 | 106-231 | Sentence | denotes | The costimulatory molecule CD28 has a restricted tissue distribution and is expressed on T cells and some plasmacytoma cells. |
| S3 | 232-400 | Sentence | denotes | Although CD28 is constitutively expressed, its expression is transiently down-regulated following T cell activation and declines progressively with in vitro senescence. |
| S4 | 401-543 | Sentence | denotes | In vivo, CD8+ T cells and, less frequently, CD4+ T cells may completely lose CD28 surface expression during chronic infections and with aging. |
| S5 | 544-680 | Sentence | denotes | This correlates with changes of nuclear protein-binding activities to two motifs, site alpha and beta, within the CD28 minimal promoter. |
| S6 | 681-804 | Sentence | denotes | Both alpha- and beta-bound complexes are found only in lymphoid tissues, in CD28+ T cells, and in some transformed B cells. |
| S7 | 805-984 | Sentence | denotes | These complexes are coordinately expressed except during replicative senescence, which is characterized by the down-modulation of site beta- but not site alpha-binding activities. |
| S8 | 985-1091 | Sentence | denotes | In contrast, T cell activation induces a parallel decline in both site alpha- and beta-binding activities. |
| S9 | 1092-1241 | Sentence | denotes | CD4+ and CD8+ T cells differ in their beta-binding profiles, which may explain the more pronounced down-regulation of CD28 in senescent CD8+ T cells. |
| S10 | 1242-1431 | Sentence | denotes | In vivo expanded CD4+CD28null and CD8+CD28null T cells uniformly lack alpha- and beta-bound complexes, resembling the pattern seen in chronically activated cells and not of senescent cells. |
genia-medco-coref
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| C1 | 14-29 | NP | denotes | CD28 expression |
| C2 | 82-104 | NP | denotes | replicative senescence |
| C3 | 106-137 | NP | denotes | The costimulatory molecule CD28 |
| C4 | 241-245 | NP | denotes | CD28 |
| C6 | 275-278 | NP | denotes | its |
| C5 | 275-289 | NP | denotes | its expression |
| C7 | 330-347 | NP | denotes | T cell activation |
| C8 | 614-624 | NP | denotes | two motifs |
| C9 | 626-645 | NP | denotes | site alpha and beta |
| C10 | 681-717 | NP | denotes | Both alpha- and beta-bound complexes |
| C11 | 805-820 | NP | denotes | These complexes |
| C12 | 862-884 | NP | denotes | replicative senescence |
| C13 | 886-891 | NP | denotes | which |
| C14 | 998-1015 | NP | denotes | T cell activation |
| C15 | 1092-1113 | NP | denotes | CD4+ and CD8+ T cells |
| C16 | 1124-1129 | NP | denotes | their |
| C17 | 1210-1214 | NP | denotes | CD28 |
| C18 | 1312-1343 | NP | denotes | alpha- and beta-bound complexes |
| R1 | C4 | C3 | coref-ident | CD28,The costimulatory molecule CD28 |
| R2 | C6 | C4 | coref-pron | its,CD28 |
| R3 | C5 | C1 | coref-ident | its expression,CD28 expression |
| R4 | C9 | C8 | coref-appos | site alpha and beta,two motifs |
| R5 | C11 | C10 | coref-ident | These complexes,Both alpha- and beta-bound complexes |
| R6 | C12 | C2 | coref-ident | replicative senescence,replicative senescence |
| R7 | C13 | C12 | coref-relat | which,replicative senescence |
| R8 | C14 | C7 | coref-ident | T cell activation,T cell activation |
| R9 | C16 | C15 | coref-pron | their,CD4+ and CD8+ T cells |
| R10 | C17 | C4 | coref-ident | CD28,CD28 |
| R11 | C18 | C11 | coref-ident | alpha- and beta-bound complexes,These complexes |
PubmedHPO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 212-224 | HP_0011857 | denotes | plasmacytoma |